ALK Rearrangement in Small-Cell Lung Cancer and Durable Response to Alectinib: A Case Report

BACKGROUND: With the development of next-generation sequencing (NGS), several anaplastic lymphoma kinase (ALK) fusion partner genes have been identified. However, ALK fusion is extremely rare in small cell lung cancer (SCLC), and there is no standard treatment option. Here, we report a patient with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ning, Zhuang, Yan, Zhang, Junling, Chen, Shiqing, Dai, Yuwen, Guo, Renhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554320/
https://www.ncbi.nlm.nih.gov/pubmed/34729013
http://dx.doi.org/10.2147/OTT.S323700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554320/
https://www.ncbi.nlm.nih.gov/pubmed/34729013
http://dx.doi.org/10.2147/OTT.S323700

Ejemplares similares